Medicure Inc. (TSXV:MPH)

Medicure Statistics

Total Valuation

Medicure has a market cap or net worth of CAD 12.00 million. The enterprise value is 8.88 million.

Market Cap	12.00M
Enterprise Value	8.88M

Important Dates

The next estimated earnings date is Tuesday, April 28, 2026.

Earnings Date	Apr 28, 2026
Ex-Dividend Date	n/a

Share Statistics

Medicure has 10.44 million shares outstanding.

Current Share Class	10.44M
Shares Outstanding	10.44M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	26.27%
Owned by Institutions (%)	0.62%
Float	5.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.46
PB Ratio	0.69
P/TBV Ratio	2.63
P/FCF Ratio	n/a
P/OCF Ratio	6.99
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.59
EV / Sales	0.34
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.06.

Current Ratio	1.44
Quick Ratio	0.97
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-69.66

Financial Efficiency

Return on equity (ROE) is -18.39% and return on invested capital (ROIC) is -19.80%.

Return on Equity (ROE)	-18.39%
Return on Assets (ROA)	-6.47%
Return on Invested Capital (ROIC)	-19.80%
Return on Capital Employed (ROCE)	-16.02%
Weighted Average Cost of Capital (WACC)	9.04%
Revenue Per Employee	689,658
Profits Per Employee	-90,237
Employee Count	38
Asset Turnover	0.95
Inventory Turnover	3.82

Taxes

In the past 12 months, Medicure has paid 279,000 in taxes.

Income Tax	279,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +43.75% in the last 52 weeks. The beta is 0.96, so Medicure's price volatility has been similar to the market average.

Beta (5Y)	0.96
52-Week Price Change	+43.75%
50-Day Moving Average	1.19
200-Day Moving Average	1.05
Relative Strength Index (RSI)	47.21
Average Volume (20 Days)	2,369

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medicure had revenue of CAD 26.21 million and -3.43 million in losses. Loss per share was -0.33.

Revenue	26.21M
Gross Profit	12.77M
Operating Income	-2.86M
Pretax Income	-3.15M
Net Income	-3.43M
EBITDA	-1.17M
EBIT	-2.86M
Loss Per Share	-0.33

Balance Sheet

The company has 4.12 million in cash and 1.00 million in debt, with a net cash position of 3.12 million or 0.30 per share.

Cash & Cash Equivalents	4.12M
Total Debt	1.00M
Net Cash	3.12M
Net Cash Per Share	0.30
Equity (Book Value)	17.31M
Book Value Per Share	1.66
Working Capital	3.91M

Cash Flow

Operating Cash Flow	1.72M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 48.71%, with operating and profit margins of -10.90% and -13.08%.

Gross Margin	48.71%
Operating Margin	-10.90%
Pretax Margin	-12.02%
Profit Margin	-13.08%
EBITDA Margin	-4.48%
EBIT Margin	-10.90%
FCF Margin	n/a

Dividends & Yields

Medicure does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-28.57%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 2, 2012. It was a reverse split with a ratio of 0.0666666.

Last Split Date	Nov 2, 2012
Split Type	Reverse
Split Ratio	0.0666666

Scores

Medicure has an Altman Z-Score of -2.2 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.2
Piotroski F-Score	3